/New Horizons 2017
New Horizons 2017 2018-07-11T09:45:05+00:00

New-Horizons-Agenda-Final-1

About New Horizons

New Horizons GIST is a conference that traditionally focuses on a large annual conference gathering over 50 representatives from 30 countries to discuss critical information about GIST that impacts the global GIST patient and medical communities. Participants have opportunities to interact with leading GIST experts, learn new medical and scientific information about GIST, exchange best practices and discuss advocacy issues.

New Horizons Presentation

Presentations

Feedback from the Global GIST Community

Presentation of Survey Results
Norman Scherzer and Michelle Durborow – The Life Raft Group
View PPT (PDF format) | View Video

 

Emerging Therapies

Emerging Therapies and Ongoing Trials in Advanced GIST

Dr. Suzanne George, Co-Clinical Director, Center for Sarcoma and Bone Oncology, Dana Farber Cancer Institute
View PPT (PDF format) | View Video

 

New Horizons Presentation

SDH Deficient GIST

Dr. Suzanne George, Co-Clinical Director, Center for Sarcoma and Bone Oncology, Dana Farber Cancer Institute
View Video

 

GIST: Harnessing the Complexities of Cancer of its Care

GIST: Harnessing the Complexities of Cancer of its Care

Dr. William Tap, Chief, Sarcoma Medical Oncology Service, Memorial Sloan Kettering Cancer Center
View PPT (PDF format) | View Video

 

New Horizons Presentation


Circulating Tumor DNA in GIST and its Implications on Treatment

Dr. Ciara Kelly, Memorial Sloan Kettering Cancer Center
View PPT (PDF format) | View Video

 

New Horizons Presentation

New Horizons Presentation

New Horizons Presentation

New Horizons Presentation

Utilization of Real World Evidence Among Different Stakeholders

View Full Presentation

Moderator: Norman Scherzer, Executive Director, The Life Raft Group
View PPT (PDF format)

Patient: Rodrigo Salas, President, Fundacion GIST Mexico
The Role of a Patient Registry in Drug Access and Coverage in Mexico
View PPT (PDF format)

Physician: Dr. Suzanne George, Co-Clinical Director, Center for Sarcoma and Bone Oncology, Dana Farber Cancer Institute
How Data Informs Clinical Guidelines

Regulatory: Dr. Theresa M. Mullin, Director, Office of Strategic Programs, FDA Center for Drug Evaluation
and Research
Patient-Focused Drug Development: Identifying and Building Needed Data Sources to Integrate Patients’ Perspectives in Decision-Making
View PPT (PDF format)

Policy: Dr. Carl Asche, Professor & Director, Center for Outcomes Research University of Illinois College of Medicine; Member of International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Evaluation of Health Care Interventions and Big Data: Review of Associated Data Issues
View PPT (PDF format)

 

New Horizons Presentation

GIST Patient Journeys: Analysis of Patient-Reported Real World Experience Highlights Progress and Remaining Medical Need

Michelle Durborow, Senior Director of Scientific Operations, The Life Raft Group
View PPT (PDF format) |View Video

 

New Horizons Presentation

Access to GIST Treatment in Low and Middle Income Countries: The Good, The Bad, and The Ugly

Pat Garcia-Gonzalez, Executive Director, The Max Foundation
View PPT (PDF format) | View Video

 

New Horizons Presentation

Patient Forums: Telling the Patient Story and its Impact on Healthcare

Gerard van Oortmerssen, Chairman of Board of Contactgroep GIST, Netherlands
 View PPT (PDF format)

 

New Horizons Presentation

Improving Patient Advocate-Patient Communication: Principles and Techniques

Amy Bruno-Lindner, President, GIST Support Österreich, Austria
View PPT (PDF format)

Photos

 

Sponsors

Blueprint Medicines

Novartis

Pfizer Logo

Core Values

Recent Posts

Upcoming Events

  1. Michigan GDOL 2018

    October 27 @ 8:00 AM - 3:00 PM